Merck & Co. Inc. buy Citigroup Inc.
Start price
25.10.24
/
50%
€96.70
Target price
25.10.25
€120.32
Performance (%)
-21.92%
End price
26.10.25
€75.50
Summary
This prediction ended on 26.10.25 with a price of €75.50. The price of Merck & Co. Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.92%. Dividends of €1.58 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 0.963% | 0.963% | 20.321% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Citigroup Inc. from $140.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€86.00
05.02.25
05.02.25
€110.32
05.02.26
05.02.26
17.91%
06.02.26
06.02.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€93.60
28.01.25
28.01.25
€119.86
28.01.26
28.01.26
-4.91%
29.01.26
29.01.26